AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

Michael J. Bennett, PhD

2018 Past President's Award

2015 AACC Academy Professor Alvin Dubin Award for Outstanding Contributions to the Profession and the Academy

2007 Award for Outstanding Contributions in a Selected Area of Research

2003 The Distinguished Scientist Award

Dr. Bennett is professor of pathology and laboratory medicine at the University of Pennsylvania, as well as chief of laboratory medicine and director of clinical chemistry and the Metabolic Disease Laboratory at Children’s Hospital of Philadelphia. He also holds the Evelyn Willing Bromley Endowed Chair in Clinical Laboratories and Pathology. Dr. Bennett’s tenure as president was another successful year for the AACC and featured a major focus on advocacy for pediatric laboratory medicine and child health. This advocacy included taking issues related to newborn screening for metabolic diseases and the lack of consistent reference ranges in pediatric laboratory medicine to officials in Washington. Dr. Bennett presented these issues to AACC members at local section meetings. The AACC hosted a workshop on newborn screening for metabolic diseases in Colombia that led to a clear plan for the country to implement a national newborn screening program. This program could be a model for other developing countries. Dr. Bennett has served the AACC in many other roles on the national, local, and division levels. For example, he has chaired the Texas Section and the Proteomics and Metabolomics Division. He served as president of the AACC Academy (when it was the National Academy of Clinical Biochemistry) and on the board of directors of the American Board of Clinical Chemistry. Dr. Bennett’s research into inborn errors of energy metabolism and pediatric neurodegenerative diseases has led to 275 peer-reviewed scientific papers, reviews, and book chapters, and two podcasts for Clinical Chemistry. He has organized numerous national and international congresses on these topics. He reviews manuscripts for more than 30 journals and is on the editorial boards of Clinical Chemistry, Annals of Clinical Biochemistry, Journal of Inherited Metabolic Diseases, and Molecular Genetics and Metabolism.